Author | Country | N | Low HDL-C | Outcomes (Low HDL-C vs Satisfactory HDL-C) |
---|---|---|---|---|
Sachdeva et al. [25] | USA | 136,905 | 55% | n/a |
Roe et al. [26] | USA | 93,263 | 53% | Significantly higher all-cause hospital mortality Significantly higher risk of multi-vessel coronary disease on angiography |
Wolfram et al. [27] | USA | 1,032 | 53% | Significant higher in-hospital mortality Significant higher major adverse cardiac events |
Pintó et al. [28] | Spain | 367 | 57% | n/a |
Arai et al. [29] | Japan | 249 | 34% | Significantly higher incidence of target lesion revascularization |
Al-Zakwani et al. [9] | Oman | 1,458 | 53% | Significant higher all-cause mortality (2.3 vs 0.6%; adjusted OR = 4.63; p=0.006) |
Correia et al. [30] | Brazil | 97 | 28% | Significant higher incidence of events (death, non-fatal myocardial infarction or recurrent unstable angina (33 vs 9%; OR = 3.6; p=0.05) |
Al-Rasadi et al. (present study) |
Middle East | 6,266 | 62% | Significant higher all-cause mortality (2.52 vs 2.36%; adjusted OR = 1.54; p=0.022) Significant higher rate of in-hospital cardiogenic shock (4.49 vs 3.61%; p=0.001) |